146
Views
8
CrossRef citations to date
0
Altmetric
Original Research

18F-FDG PET/MR Assessment of Pediatric Langerhans Cell Histiocytosis

, , , , , , & show all
Pages 6251-6259 | Published online: 01 Oct 2021

References

  • Poompuen S, Chaiyarit J, Techasatian L. Diverse cutaneous manifestation of Langerhans cell histiocytosis: a 10-year retrospective cohort study. Eur J Pediatr. 2019;178(5):771–776. doi:10.1007/s00431-019-03356-1
  • Monsereenusorn C, Rodriguez-Galindo C. Clinical characteristics and treatment of Langerhans cell histiocytosis. Hematol Oncol Clin North Am. 2015;29(5):853–873. doi:10.1016/j.hoc.2015.06.005
  • Chu T, Jaffe R. The normal Langerhans cell and the LCH cell. Br J Cancer Suppl. 1994;23:S4–S10.
  • Papo M, Cohen-Aubart F, Trefond L, et al. Systemic histiocytosis (Langerhans cell histiocytosis, Erdheim-Chester disease, Destombes-Rosai-Dorfman disease): from oncogenic mutations to inflammatory disorders. Curr Oncol Rep. 2019;21(7):62. doi:10.1007/s11912-019-0810-6
  • Weitzman S, Egeler RM. Langerhans cell histiocytosis: update for the pediatrician. Curr Opin Pediatr. 2008;20(1):23–29. doi:10.1097/MOP.0b013e3282f45ba4
  • Heritier S, Emile JF, Barkaoui MA, et al. BRAF mutation correlates with high-risk Langerhans cell histiocytosis and increased resistance to first-line therapy. J Clin Oncol. 2016;34(25):3023–3030. doi:10.1200/JCO.2015.65.9508
  • Zhang X, Zhou J, Chai X, et al. The application of x-ray, computed tomography, and magnetic resonance imaging on 22 pediatric Langerhans cell histiocytosis patients with long bone involvement: a retrospective analysis. Medicine. 2018;97(17):e0411. doi:10.1097/MD.0000000000010411
  • Girschikofsky M, Arico M, Castillo D, et al. Management of adult patients with Langerhans cell histiocytosis: recommendations from an expert panel on behalf of Euro-Histio-Net. Orphanet J Rare Dis. 2013;8(1):72. doi:10.1186/1750-1172-8-72
  • Van Nieuwenhuyse J-P, Clapuyt P, Malghem J, et al. Radiographic skeletal survey and radionuclide bone scan in Langerhans cell histiocytosis of bone. Pediatr Radiol. 1996;26(10):734–738. doi:10.1007/BF01383393
  • Phillips M, Allen C, Gerson P, McClain K. Comparison of FDG-PET scans to conventional radiography and bone scans in management of Langerhans cell histiocytosis. Pediatr Blood Cancer. 2009;52(1):97–101. doi:10.1002/pbc.21782
  • Grois N, Fahrner B, Arceci RJ, et al. Central nervous system disease in Langerhans cell histiocytosis. J Pediatr. 2010;156(6):873–881 e1. doi:10.1016/j.jpeds.2010.03.001
  • Kim JR, Yoon HM, Jung AY, Cho YA, Seo JJ, Lee JS. Comparison of whole-body MRI, bone scan, and radiographic skeletal survey for lesion detection and risk stratification of Langerhans cell histiocytosis. Sci Rep. 2019;9(1):317. doi:10.1038/s41598-018-36501-1
  • Zhou W, Wu H, Han Y, Wang S, Dong Y, Wang Q. Preliminary study on the evaluation of Langerhans cell histiocytosis using F-18-fluoro-deoxy-glucose PET/CT. Chin Med J. 2014;127(13):2458–2462.
  • Feng Q, Liang J, Wang L, et al. Radiomics analysis and correlation with metabolic parameters in nasopharyngeal carcinoma based on PET/MR imaging. Front Oncol. 2020;10:1619. doi:10.3389/fonc.2020.01619
  • Paspulati RM, Gupta A. PET/MR imaging in cancers of the gastrointestinal tract. PET Clin. 2016;11(4):403–423. doi:10.1016/j.cpet.2016.05.004
  • Schafer JF, Gatidis S, Schmidt H, et al. Simultaneous whole-body PET/MR imaging in comparison to PET/CT in pediatric oncology: initial results. Radiology. 2014;273(1):220–231. doi:10.1148/radiol.14131732
  • DiCaprio MR, Roberts TT. Diagnosis and management of Langerhans cell histiocytosis. J Am Acad Orthop Surg. 2014;22(10):643–652. doi:10.5435/JAAOS-22-10-643
  • Mueller WP, Melzer HI, Schmid I, Coppenrath E, Bartenstein P, Pfluger T. The diagnostic value of 18F-FDG PET and MRI in paediatric histiocytosis. Eur J Nucl Med Mol Imaging. 2013;40(3):356–363. doi:10.1007/s00259-012-2278-6
  • Sher AC, Orth R, McClain K, Allen C, Hayatghaibi S, Seghers V. PET/MR in the assessment of pediatric histiocytoses: a comparison to PET/CT. Clin Nucl Med. 2017;42(8):582–588. doi:10.1097/RLU.0000000000001717
  • Luna LP, Drier A, Aygun N, et al. MRI features of intra-axial histiocytic brain mass lesions. Clin Radiol. 2021;76(2):159e19–159 e28. doi:10.1016/j.crad.2020.09.015
  • Shapira-Zaltsberg G, Wilson N, Trejo Perez E, et al. Whole-body diffusion-weighted MRI compared to 18 F FDG PET/CT in initial staging and therapy response assessment of Hodgkin lymphoma in pediatric patients. Can Assoc Radiol J. 2020;71(2):217–225. doi:10.1177/0846537119888380
  • Ginat DT, Johnson DN, Cipriani NA. Langerhans cell histiocytosis of the temporal bone. Head Neck Pathol. 2016;10(2):209–212. doi:10.1007/s12105-015-0629-x
  • Seely JM, Salahudeen S Sr, Cadaval-Goncalves AT, et al. Pulmonary Langerhans cell histiocytosis: a comparative study of computed tomography in children and adults. J Thorac Imaging. 2012;27(1):65–70. doi:10.1097/RTI.0b013e3181f49eb6
  • Smets A, Mortele K, de Praeter G, Francois O, Benoit Y, Kunnen M. Pulmonary and mediastinal lesions in children with Langerhans cell histiocytosis. Pediatr Radiol. 1997;27(11):873–876. doi:10.1007/s002470050260
  • Yi X, Han T, Zai H, Long X, Wang X, Li W. Liver involvement of Langerhans’ cell histiocytosis in children. Int J Clin Exp Med. 2015;8(5):7098–7106.
  • Shi Y, Qiao Z, Xia C, et al. Hepatic involvement of Langerhans cell histiocytosis in children–imaging findings of computed tomography, magnetic resonance imaging and magnetic resonance cholangiopancreatography. Pediatr Radiol. 2014;44(6):713–718. doi:10.1007/s00247-014-2886-3
  • Schmidt S, Eich G, Geoffray A, et al. Extraosseous Langerhans cell histiocytosis in children. Radiographics. 2008;28(3):707–26;quiz 910–1. doi:10.1148/rg.283075108